Cardiovasoactive Peptides in Hemodialysis Patients: Diagnostic Tools and Predictors of Outcome: A Review of Present Knowledge and Future Directions

This publication has 50 references indexed in Scilit:

• Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP
  Nephrology Dialysis Transplantation, 1996
• Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction
  American Heart Journal, 1994
• Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
  Published by Elsevier ,1993
• Plasma concentrations of calcitonin gene-related peptide in fluid overload
  The Lancet, 1991
• Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.
  Hypertension, 1991
• Atrial natriuretic peptide in congestive heart failure
  The American Journal of Cardiology, 1988
• Influence of sodium intake on circulating levels of neuropeptide Y
  Life Sciences, 1987
• Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure
  New England Journal of Medicine, 1986
• Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)
  Biochemical and Biophysical Research Communications, 1984
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
  Life Sciences, 1981